This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech

Altera Leads S&P 500 on Deal Talk; Stocks Kick Off May With Rally

Altera (ALTR) was the best performer on the S&P 500 on reports Intel (INTC) could launch a hostile bid once a standstill agreement expires on June 1st.

05/01/15 - 04:38 PM EDT

As Stocks Flirt With All-Time Highs, Investors Should Be 'On Edge' About a Correction

Stocks may be flirting with record highs, but don't get too comfortable, one strategist warns.

05/01/15 - 03:08 PM EDT

Despite April's Rocky Finish, Don't Sell in May and Go Away

Despite April's Rocky Finish, Don't Sell in May and Go Away

This year, the CNBC 'Fast Money Halftime' traders aren't following the classic strategy of getting out of the market during the summer doldrums, because now, they see a buying opportunity.

05/01/15 - 02:52 PM EDT

Jim Cramer -- BioMarin, Receptos Will Re-Test Highs, Biotech Will Recover

Jim Cramer -- BioMarin, Receptos Will Re-Test Highs, Biotech Will Recover

TheStreet's Jim Cramer says the rally in biotech stocks is far from over.

05/01/15 - 11:40 AM EDT

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Biotech columnist Adam Feuerstein answers readers' questions about health care.

05/01/15 - 08:31 AM EDT

Apple Leads Dow Lower; Wall Street Slumps on Biotech Selloff

Apple Leads Dow Lower; Wall Street Slumps on Biotech Selloff

Stocks slumped on Thursday, leaving the Dow with only small gains for the month.

04/30/15 - 04:35 PM EDT

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

  • Tickers in this article:
  • MNKD
  • SNY

Sales of MannKind's inhaled insulin Afrezza totaled €1 million in the first quarter of its commercial launch.

04/30/15 - 06:51 AM EDT

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

  • Tickers in this article:
  • MNKD
  • SNY

Sanofi reports first-quarter earnings on Thursday morning, but it's unclear if sales of the recently launched inhaled insulin medication Afrezza will be disclosed.

04/29/15 - 01:18 PM EDT

Mylan, Perrigo Active on Boosted Bid; Starwood Explores Options

Mylan, Perrigo Active on Boosted Bid; Starwood Explores Options

Stocks were lower in midday trading Wednesday after U.S. economic growth turned anemic in the first quarter.

04/29/15 - 12:00 PM EDT

Mylan (MYL) Stock Rises After Increasing Perrigo Offer a Second Time

Mylan (MYL) Stock Rises After Increasing Perrigo Offer a Second Time

  • Tickers in this article:
  • MYL

Mylan (MYL) shares are climbing after the company upped its bid for Perrigo to approximately $35.6 billion.

04/29/15 - 10:09 AM EDT

Twitter, Procter & Gamble Are Downgraded; Eli Lilly Gets a Boost

Twitter, Procter & Gamble Are Downgraded; Eli Lilly Gets a Boost

In Wednesday's Analysts' Actions, we highlight downgrades for Twitter (TWTR) and Procter & Gamble (PG) as well as an upgrade for Eli Lilly (LLY).

04/29/15 - 10:46 AM EDT

Here's What's Next as BioMarin Moves Closer to Duchenne Drug Approval

Here's What's Next as BioMarin Moves Closer to Duchenne Drug Approval

Will the FDA bring together DMD experts for a single meeting to review both BioMarin's drisapersen and Sarepta's eteplirsen, or will two separate meetings be scheduled?

04/28/15 - 12:09 PM EDT

Bristol Myers Beats on Earnings, Cancer Drug Sales Disappoint

Bristol Myers Beats on Earnings, Cancer Drug Sales Disappoint

  • Tickers in this article:
  • BMY

Drug maker Bristol Myers (BMY) posted earnings of $0.71 per share on Tuesday, beating analyst estimates.

04/28/15 - 12:05 PM EDT

Pfizer Tops Estimates but Cuts 2015 Outlook Due to Strong Dollar

Pfizer Tops Estimates but Cuts 2015 Outlook Due to Strong Dollar

  • Tickers in this article:
  • PFE

Pfizer's (PFE) new drugs pipeline gave their first quarter earnings a boost on Tuesday.

04/28/15 - 11:10 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs